Alkermes Plc reports results for the quarter ended in March - Earnings Summary

Alkermes

01/05/2024 14:32

* Alkermes Plc  ALKS.OQ  reported quarterly adjusted
earnings of
43 cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of 1
cents.  The mean expectation of ten analysts for the quarter was
for earnings of 58 cents per share. Wall Street expected
results to range from 52 cents to 66 cents per share.
    * Revenue rose 21.8% to $350.37 million from a year ago;
analysts
expected $360.26 million. 
    * Alkermes Plc's reported EPS for the quarter was 23 cents​.
    * The company reported quarterly net income of $36.8
million.
    * Alkermes Plc shares had fallen by 9.3% this quarter and
lost 11.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.9%
in the last three months.​ 
    * In the last 30 days, six analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Alkermes Plc is
$35.00 
This summary was machine generated from LSEG data May 1 at 01:31
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.58           0.43           Missed
 Dec. 31 2023      0.51           0.22           Missed
 Sep. 30 2023      0.44           0.64           Beat
 Jun. 30 2023      0.46           0.55           Beat